Cost and Cost-effectiveness of PTB+ Treatment in Southern Ethiopia
Evidences for policy making and decision related to the cost of delivering tuberculosis (TB) control is lacking in Ethiopia. The investigators aimed to determine the cost and cost-effectiveness of involving health extension workers (HEWs) in TB treatment under the community-based initiative in Ethiopia.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Improving Community Based TB Care in Southern Ethiopia Cost and Cost Effectiveness|
- cost per successfully treated smear-positive case [ Time Frame: September 2006 to April 2008 ] [ Designated as safety issue: Yes ]
|Study Start Date:||September 2006|
|Study Completion Date:||April 2008|
|Primary Completion Date:||March 2007 (Final data collection date for primary outcome measure)|
Directly Observed Treatment under Health Extension Workers
Directly observed treatment (DOT) by health extension workers (HEWs)
Other Name: community based TB care
Directly observed treatment under general health workers
Two treatment options were compared - health facility and community DOT. In 1995, Ethiopia adopted World Health Organization (WHO) recommended DOTS strategy for TB control. The treatment regimen for new smear-positive patients includes two months of ethambutol, rifampicin, isoniazid and pyrazinamide followed by six months of ethambutol and isoniazid. For children the continuation phase treatment was replaced by four months of rifampicin and isoniazid. Follow up sputum examinations were conducted at the end of 2, 5 and 7 months treatment.